## MAR: Marriott International - XLY: Consumer Cyclical

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 5.9% in upper entry zone (3.0-6.0%), top 8% cross-sectional ranking. Short-term MRS_5 (6.2%) confirms momentum alignment. Strong momentum (+11.7% 5-day acceleration).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($294.29)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Here Are Monday’s Top Wall Street Analyst Research Calls: Bristol-Myers Squibb, GE Vernova, KLA Corp., Klaviyo, Las Vegas Sands, ServiceNow, and More**
- Source: 24/7 Wall St. | 20251215T131857 | Bullish | Relevance: 87%
- This article details top Wall Street analyst upgrades, downgrades, and initiations for Monday, December 15, 2025, covering several prominent companies including Bristol-Myers Squibb, GE Vernova, and ServiceNow. It also provides a snapshot of the market's performance, highlighting a rotation out of AI stocks and general market volatility. The report includes updates on pre-market stock futures, treasury bonds, oil and gas, gold, and cryptocurrency markets.

**2. Here Are Monday’s Top Wall Street Analyst Research Calls: Bristol-Myers Squibb, GE Vernova, KLA Corp., Klaviyo, Las Vegas Sands, ServiceNow, and More**
- Source: Yahoo Finance | 20251215T150757 | Bullish | Relevance: 79%
- This article details top Wall Street analyst upgrades, downgrades, and initiations announced on Monday, December 15, 2025, for various companies including Bristol-Myers Squibb, GE Vernova, KLA Corp., and ServiceNow. It also touches upon the general market sentiment, noting a rotation out of AI stocks and mixed performance across different asset classes like Treasury bonds, oil, gold, and cryptocurrency. The market volatility is expected to continue towards the year-end.

**3. Jim Cramer Recently Talked About These 7 Travel and Leisure Stocks**
- Source: Insider Monkey | 20251213T060820 | Somewhat-Bullish | Relevance: 65%
- Jim Cramer has highlighted Booking Holdings Inc. (NASDAQ:BKNG) as a resilient travel and leisure stock, preferring it over competitors like Expedia due to its superior operations and strong performance. The company's focus on direct bookings and fragmented hotel suppliers in ex-U.S. markets has been key to its success, allowing it to reinvest in advertising and maintain a differentiated position in the industry. Wedgewood Partners also noted Booking Holdings' strong revenue and earnings growth.

**4. Emirates & Delta Airlines Brace for Massive Tourism Surge as H World Group’s Hotel Empire Expands — What This Means for Travel in China, France, and Spain in 2025**
- Source: Travel And Tour World | 20251213T070946 | Somewhat-Bullish | Relevance: 65%
- The rapid expansion of H World Group's hotel empire is poised to revolutionize global tourism as major airlines like Emirates and Delta prepare for a significant surge in demand in 2025. This growth will particularly impact travel to China, France, and Spain, offering more accommodation choices and enhanced flight connectivity for travelers. The increased infrastructure and services are expected to make these destinations more accessible and enjoyable for international visitors.

**5. Stocks making the biggest moves midday: Zillow, KLA, iRobot, Immunome & more**
- Source: CNBC | 20251215T124600 | Somewhat-Bullish | Relevance: 63%
- This article details the midday stock movements of several companies. KLA surged on an analyst upgrade linked to AI, while Immunome saw a significant rise following positive trial results for its new drug. iRobot plummeted after declaring bankruptcy, and stocks like Alibaba and Baidu dipped due to new data indicating an economic slowdown in China.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-15 | Goldman Sachs | $345 | $288 | +20% |
| 2025-12-04 | Truist Securiti | $283 | $278 | +2% |
| 2025-11-18 | Wells Fargo | $329 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-15 | Goldman Sachs | up | Buy |
| 2025-12-04 | Truist Securiti | main | Hold |
| 2025-11-18 | Wells Fargo | init | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 5 ($0.45M) |
| Sells | 12 ($25.61M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 35.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 7.7% (+1.1%)
- Blackrock Inc.: 5.7% (+0.3%)
- JPMORGAN CHASE & CO: 5.0% (+40.6%)
- State Street Corpora: 3.5% (-0.3%)
- Wellington Managemen: 3.4% (+21.7%)

### Key Risks

1. Heavy insider selling: $26M sold (12 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +11.7% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.61 elevated, pricing in significant growth expectations. Forward P/E 27.1x stretched relative to 13% growth. Quality metrics strong (margin 38%). Analyst sentiment positive (2 raises, avg +11%). Insider selling cluster ($25.6M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $83.7B |
| Beta | 1.16 |
| 52W Range | $205.40 - $310.23 |
| Short Interest | 3.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.61 |
| Forward P/E | 27.1 |
| Current P/E | 30.5 |
| YoY Growth | 12.7% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -5.8% to 5.9% (+11.7% in 5 days), confirming momentum buildup. Currently in upper STRENGTH zone (3.0-6.0%), cross-sectional ranking at 91st percentile. MRS_5 at 6.2% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: +MTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 5.93% (CS: 92) | Strong |
| RSI_14 | 65.2 | Neutral |
| MACD Histogram | -0.43 | Bearish |
| vs SMA20 | 1.045x | Above |
| vs SMA50 | 1.097x | Above |
| vs SMA200 | 1.168x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $308.49
- **Stop Loss:** $294.29 (4.6% risk)
- **Target:** $329.79 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 84
- **Position Value:** $25,913.16
- **Portfolio %:** 25.91%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-02-10 (Est: $2.61)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.39 | $2.47 | +3.5% |
| 2025Q2 | $2.62 | $2.65 | +1.1% |
| 2025Q1 | $2.25 | $2.32 | +3.0% |
| 2024Q4 | $2.38 | $2.45 | +2.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*